Global Bio-chem Technology Group Company Limited EBIT

Global Bio-chem Technology Group Company Limited (GBCMY) currently reports a EBIT of $-340M as of June 2026. That compares with $4B in the prior-year period — down 108.5% year over year. That is below the sector sector average of $2.7T. Use the charts on this page to explore Global Bio-chem Technology Group Company Limited's EBIT history and peer comparisons.

Global Bio-chem Technology Group Company Limited's EBIT decreased from $4B to $-340M — a 108.5% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Global Bio-chem Technology Group Company Limited's EBIT of $-340M is lower than the its sector sector average of $2.7T. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Global Bio-chem Technology Group Company Limited reported $-340M in EBIT as of June 2026. That compares with $4B in the prior-year period — down 108.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-340M, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is $2.7T. From there, open related valuation or income-statement pages for Global Bio-chem Technology Group Company Limited, and consider following GBCMY for alerts when major investors trade the stock.